Supriya Lifescience Limited IPO (Supriya Lifescience IPO) – Review and Details

Supriya Lifescience IPO

The Supriya Lifescience IPO open date is Dec 16, 2021. Supriya Lifescience manufactures Active pharmaceutical ingredients (APIs). It produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic as of March 2021. 

Supriya Lifescience IPO

The Supriya Lifescience has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between the Fiscal year 2017 and 2021. It is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021

In the year 2021, the company’s products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.

The company’s manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.

Also check: Upcoming IPOs List 2021

Supriya Lifescience IPO – Financial Information

Here is the list of Supriya Lifescience limited financial information.

30-Sep-2131-Mar-2131-Mar-2031-Mar-19
Total Assets5,041.024,458.243,364.012,530.52
Total Revenue2,300.613,962.213,227.132,858.62
Profit After Tax659.591,238.28733.74394.24

Supriya Lifescience IPO – Objects of the Issue

The net proceeds from the IPO will be utilized for the following purposes

  • Funding capital expenditure requirements of the company
  • Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company
  • General corporate purposes

Supriya Lifescience IPO – IPO Details

Here is the list of the IPO Details of Supriya Lifescience Limited.

IPO Opening DateDec 16, 2021
IPO Closing DateDec 20, 2021
Issue TypeBook Built Issue IPO
Face ValueRs 2 per equity share
IPO PriceRs 265 to Rs 274 per equity share
Market Lot54 Shares
Min Order Quantity54 Shares
Listing AtBSE, NSE
Issue SizeEq Shares of Rs 2(aggregating up to Rs 700.00 Cr)
Fresh IssueEq Shares of Rs 2(aggregating up to Rs 200.00 Cr)
Offer for SaleEq Shares of Rs 2(aggregating up to Rs 500.00 Cr)
QIB Shares OfferedNot less than 75% of the Offer
Retail Shares OfferedNot more than 10% of the Offer
NII (HNI) Shares OfferedNot more than 15% of the Offer

Supriya Lifescience IPO – Tentative Timetable

The Supriya Lifescience IPO open date is Dec 16, 2021, and the close date is Dec 20, 2021. The issue may list on Dec 28, 2021.

IPO Open DateDec 16, 2021
IPO Close DateDec 20, 2021
Basis of Allotment DateDec 23, 2021
Initiation of RefundsDec 24, 2021
Credit of Shares to Demat AccountDec 27, 2021
IPO Listing DateDec 28, 2021

Supriya Lifescience IPO – Lot Size

The Supriya Lifescience IPO market lot size is 35 shares. A retail-individual investor can apply for up to 13 lots which is 455 shares or Rs 193,375.

ApplicationLotsSharesAmount (Cut-off)
Minimum154Rs 14,796
Maximum13702Rs 192,348

Company Contact Information

Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon,
East, Mumbai – 400063, Maharashtra, India
Phone: +91-22-40332727
Email: cs@supriyalifescience.com
Website: https://supriyalifescience.com/

Supriya Lifescience IPO Registrar

Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: supriyalife.ipo@linkintime.co.in
Website: https://linkintime.co.in/

investobull
Investobull.com is a one stop place for all Finance resources We write on Finance , Trading , Investments and Economics. Follow us on Twitter , facebook and Youtube